Index by author
April 01, 2000; Volume 28,Issue 4
A
Abraham, Trent L.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
Anders, M.W.
- You have accessPorcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-ConjugatesTorsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine WolfDrug Metabolism and Disposition April 2000, 28 (4) 440-445;
Attolini, Laurence
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
B
Baker, David S.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Barthen, Mary T.
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Bayse, Gladys S.
- You have accessThe N-Acetylation of Arsanilic Acid In Vitro by Mammalian EnzymesGladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. WileyDrug Metabolism and Disposition April 2000, 28 (4) 487-492;
Benoit, Etienne
- You have accessThioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)Cendrine Sevoz, Etienne Benoit and Thierry BuronfosseDrug Metabolism and Disposition April 2000, 28 (4) 398-402;
Blanco, Javier G.
- You have accessHuman Cytochrome P450 Maximal Activities In Pediatric versus Adult LiverJavier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. RellingDrug Metabolism and Disposition April 2000, 28 (4) 379-382;
Bombardt, Paul A.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Bruguerolle, Bernard
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
Buckpitt, Alan R.
- You have accessSpecies Differences in The Regio- and Stereoselectivity of 1-Nitronaphthalene MetabolismKatherine C. Watt and Alan R. BuckpittDrug Metabolism and Disposition April 2000, 28 (4) 376-378;
Buronfosse, Thierry
- You have accessThioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)Cendrine Sevoz, Etienne Benoit and Thierry BuronfosseDrug Metabolism and Disposition April 2000, 28 (4) 398-402;
C
Cathcart, Karen Sue
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Chay, Sylvia H.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
Chen, I-Wu
- You have accessRoute-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme InactivationJiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLunaDrug Metabolism and Disposition April 2000, 28 (4) 460-466;
Chiba, Masato
- You have accessRoute-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme InactivationJiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLunaDrug Metabolism and Disposition April 2000, 28 (4) 460-466;
Compton, Linda D.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Czeskis, Boris A.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
D
Dailey, Harry A.
- You have accessN-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken FerrochelataseJeremy T. Gamble, Harry A. Dailey and Gerald S. MarksDrug Metabolism and Disposition April 2000, 28 (4) 373-375;
deLuna, Florencia A.
- You have accessRoute-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme InactivationJiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLunaDrug Metabolism and Disposition April 2000, 28 (4) 460-466;
Dieckhaus, Christine M.
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Durand, Alain
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
E
Evans, William E.
- You have accessHuman Cytochrome P450 Maximal Activities In Pediatric versus Adult LiverJavier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. RellingDrug Metabolism and Disposition April 2000, 28 (4) 379-382;
F
Feenstra, Kenneth L.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Funae, Yoshihiko
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Fung, Ho-Leung
- You have accessPharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in RatsWilliam Kielbasa and Ho-Leung FungDrug Metabolism and Disposition April 2000, 28 (4) 386-391;
G
Gamble, Jeremy T.
- You have accessN-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken FerrochelataseJeremy T. Gamble, Harry A. Dailey and Gerald S. MarksDrug Metabolism and Disposition April 2000, 28 (4) 373-375;
Gantenbein, Manon
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
Green, Carol E.
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Greenblatt, David J.
- You have accessIn Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug InteractionsJill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition April 2000, 28 (4) 392-397;
H
Hardwigsen, Jean
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
Harrison, Patricia L.
- You have accessHuman Cytochrome P450 Maximal Activities In Pediatric versus Adult LiverJavier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. RellingDrug Metabolism and Disposition April 2000, 28 (4) 379-382;
He, Minxia M.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
I
Imaoka, Susumu
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Ito, Kiyomi
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
J
Jinadu, Laide A.
- You have accessThe N-Acetylation of Arsanilic Acid In Vitro by Mammalian EnzymesGladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. WileyDrug Metabolism and Disposition April 2000, 28 (4) 487-492;
Johnson, Mark G.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Johnston, Thomas P.
- You have accessPharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley RatsKameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. MitraDrug Metabolism and Disposition April 2000, 28 (4) 403-408;
K
Kanamitsu, Shin-ichi
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Kasahara, Mie
- You have accessStudies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP IsoformsMie Kasahara, Hisashi Suzuki and Izumi KomiyaDrug Metabolism and Disposition April 2000, 28 (4) 409-417;
Kielbasa, William
- You have accessPharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in RatsWilliam Kielbasa and Ho-Leung FungDrug Metabolism and Disposition April 2000, 28 (4) 386-391;
Komatsu, Kanji
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Komiya, Izumi
- You have accessStudies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP IsoformsMie Kasahara, Hisashi Suzuki and Izumi KomiyaDrug Metabolism and Disposition April 2000, 28 (4) 409-417;
Kraus, Torsten
- You have accessPorcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-ConjugatesTorsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine WolfDrug Metabolism and Disposition April 2000, 28 (4) 440-445;
Kuchimanchi, Kameswara R.
- You have accessPharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley RatsKameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. MitraDrug Metabolism and Disposition April 2000, 28 (4) 403-408;
L
Lacarelle, Bruno
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
Le-Treut, Yves-Patrice
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
Lin, Jiunn H.
- You have accessRoute-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme InactivationJiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLunaDrug Metabolism and Disposition April 2000, 28 (4) 460-466;
Lindsay, Thomas J.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
Lord, Raymond S.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
M
Macdonald, Timothy L.
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Madelmont, Jean-Claude
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
Marks, Gerald S.
- You have accessN-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken FerrochelataseJeremy T. Gamble, Harry A. Dailey and Gerald S. MarksDrug Metabolism and Disposition April 2000, 28 (4) 373-375;
Maurizis, Jean-Claude
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
Miller, Langdon L.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Miller, Thomas A.
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Mitra, Ashim K.
- You have accessPharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley RatsKameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. MitraDrug Metabolism and Disposition April 2000, 28 (4) 403-408;
Mohri, Kiminori
- You have accessEffects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit JuiceKiminori Mohri, Yoshihiro Uesawa and Ken-ichi SagawaDrug Metabolism and Disposition April 2000, 28 (4) 482-486;
Muro, Kei
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
N
Nakajima, Yukiko
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Nicolas, Colette
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
Nishime, Joy A.
- You have accessRoute-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme InactivationJiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLunaDrug Metabolism and Disposition April 2000, 28 (4) 460-466;
O
Ogura, Kenichiro
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
Okuda, Haruhiro
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
Ollier, Monique
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
P
Pearson, Laura K.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Pesheck, Caroline V.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Puyoou, Franck
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
R
Rapp, Maryse
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
Relling, Mary V.
- You have accessHuman Cytochrome P450 Maximal Activities In Pediatric versus Adult LiverJavier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. RellingDrug Metabolism and Disposition April 2000, 28 (4) 379-382;
S
Sagawa, Ken-ichi
- You have accessEffects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit JuiceKiminori Mohri, Yoshihiro Uesawa and Ken-ichi SagawaDrug Metabolism and Disposition April 2000, 28 (4) 482-486;
Sams, James P.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Schaaf, Larry J.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Sevoz, Cendrine
- You have accessThioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)Cendrine Sevoz, Etienne Benoit and Thierry BuronfosseDrug Metabolism and Disposition April 2000, 28 (4) 398-402;
Shader, Richard I.
- You have accessIn Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug InteractionsJill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition April 2000, 28 (4) 392-397;
Shaw, Kiana L.
- You have accessThe N-Acetylation of Arsanilic Acid In Vitro by Mammalian EnzymesGladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. WileyDrug Metabolism and Disposition April 2000, 28 (4) 487-492;
Shimada, Noriaki
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Shipley, Lisa A.
- You have accessMetabolism and Disposition of Moxonidine in Fischer 344 RatsMinxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. ShipleyDrug Metabolism and Disposition April 2000, 28 (4) 446-459;
Slatter, John Greg
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Sofia, R. Duane
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Sugiyama, Yuichi
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
Suzuki, Hisashi
- You have accessStudies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP IsoformsMie Kasahara, Hisashi Suzuki and Izumi KomiyaDrug Metabolism and Disposition April 2000, 28 (4) 409-417;
T
Thompson, Charles D.
- You have accessThe Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of FelbamateCharles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. MacdonaldDrug Metabolism and Disposition April 2000, 28 (4) 434-439;
Tyson, Charles A.
- You have accessPrediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro ExperimentsKanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 475-481;
U
Udata, Chandrasekhar
- You have accessPharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley RatsKameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. MitraDrug Metabolism and Disposition April 2000, 28 (4) 403-408;
Uesawa, Yoshihiro
- You have accessEffects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit JuiceKiminori Mohri, Yoshihiro Uesawa and Ken-ichi SagawaDrug Metabolism and Disposition April 2000, 28 (4) 482-486;
Uttamsingh, Viuita
- You have accessPorcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-ConjugatesTorsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine WolfDrug Metabolism and Disposition April 2000, 28 (4) 440-445;
V
Verburg, Michael T.
- You have accessPharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer PatientsJohn Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. LordDrug Metabolism and Disposition April 2000, 28 (4) 423-433;
Verny, Michel
- You have accessDisposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging AgentsJean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude MadelmontDrug Metabolism and Disposition April 2000, 28 (4) 418-422;
Villard, Pierre-Henri
- You have accessOxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3AManon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-TreutDrug Metabolism and Disposition April 2000, 28 (4) 383-385;
von Moltke, Lisa L.
- You have accessIn Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug InteractionsJill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition April 2000, 28 (4) 392-397;
W
Warrington, Jill S.
- You have accessIn Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug InteractionsJill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition April 2000, 28 (4) 392-397;
Watabe, Tadashi
- You have accessPrediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracilShin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi SugiyamaDrug Metabolism and Disposition April 2000, 28 (4) 467-474;
Watt, Katherine C.
- You have accessSpecies Differences in The Regio- and Stereoselectivity of 1-Nitronaphthalene MetabolismKatherine C. Watt and Alan R. BuckpittDrug Metabolism and Disposition April 2000, 28 (4) 376-378;
Wiley, Kelita L.
- You have accessThe N-Acetylation of Arsanilic Acid In Vitro by Mammalian EnzymesGladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. WileyDrug Metabolism and Disposition April 2000, 28 (4) 487-492;
Wolf, Sabine
- You have accessPorcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-ConjugatesTorsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine WolfDrug Metabolism and Disposition April 2000, 28 (4) 440-445;